Is Enanta Pharmaceuticals, Inc. (ENTA) a Buy, Sell, or Hold?
NASDAQ : ENTA
Enanta Pharmaceuticals, Inc.
$13.23 USD
$0.12 (0.92%)
- Volume
- 97.46K
- Average Volume
- 212.6K
- Market Capitalization
- $307.16M
- P/E Ratio
- -4.83
- Dividend Yield
- 0.00%
- Price Target
- $20.00
- Year High
- $17.15
- Year Low
- $6.44
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.84
CCURRENT INSTITUTIONAL OWNERSHIP PERCENTAGE
0.08%
Investors Holding
4
change: -130 | last: 134
Increased Positions
0
change: -71 | last: 71
Reduced Positions
2
change: -32 | last: 34
New Positions
0
change: -24 | last: 24
Sold Positions
127
change: 104 | last: 23
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -38.1201 | last: 0.3812
Total Invested
223.79K
ENTA Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-09-30 | $11.97 | 21.34M | $255.39M | $32.3M | $201.06M | $424.15M |
| 2024-09-30 | $10.36 | 21.16M | $219.19M | $37.23M | $226.06M | $408.01M |
| 2023-09-30 | $11.17 | 20.97M | $234.22M | $85.39M | $26.51M | $175.35M |
| 2022-09-30 | $51.87 | 20.6M | $1.07B | $43.99M | $26.69M | $1.05B |
| 2021-09-30 | $56.81 | 20.17M | $1.15B | $57.21M | $6.84M | $1.1B |
| 2020-09-30 | $45.78 | 19.94M | $912.85M | $87.13M | $9.58M | $835.3M |
| 2019-09-30 | $60.08 | 19.58M | $1.18B | $51.23M | $200K | $1.13B |
| 2018-09-30 | $84.11 | 20.65M | $1.74B | $63.9M | $293K | $1.67B |
| 2017-09-30 | $46.80 | 19.07M | $892.29M | $65.68M | $458K | $827.07M |
| 2016-09-30 | $26.61 | 18.93M | $503.7M | $16.58M | $531K | $487.65M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $12.63 | 21.38M | $270.03M | $34.93M | $186.62M | $421.72M |
| 2025-12-31 | $15.77 | 21.38M | $337.16M | $37.44M | $193.18M | $492.91M |
| 2025-09-30 | $11.97 | 21.38M | $255.92M | $32.3M | $201.06M | $424.68M |
| 2025-06-30 | $7.56 | 21.32M | $161.19M | $44.81M | $207.1M | $323.48M |
| 2025-03-31 | $5.52 | 21.36M | $117.88M | $60.21M | $216.14M | $273.81M |
| 2024-12-31 | $5.75 | 21.24M | $122.12M | $84.35M | $221.29M | $259.06M |
| 2024-09-30 | $10.36 | 21.19M | $219.53M | $37.23M | $226.06M | $408.35M |
| 2024-06-30 | $13.07 | 21.18M | $276.82M | $35.78M | $226.17M | $467.22M |
| 2024-03-31 | $17.02 | 21.17M | $360.26M | $63.54M | $229.86M | $526.58M |
| 2023-12-31 | $9.41 | 21.09M | $198.44M | $39.93M | $220M | $378.51M |
| 2023-09-30 | $11.17 | 21.06M | $235.21M | $85.39M | $222.44M | $372.26M |
| 2023-06-30 | $21.40 | 21.05M | $450.56M | $95.18M | $230.8M | $586.17M |